login
login

Europe Daily Bulletin No. 12813

16 October 2021
Contents Publication in full By article 16 / 28
EU RESPONSE TO COVID-19 / Health
European Medicines Agency begins to evaluate AstraZeneca’s Covid-19 treatment
Brussels, 15/10/2021 (Agence Europe)

On Thursday 14 October, the European Medicines Agency (EMA) announced that it had begun evaluating a new candidate treatment for Covid-19 developed by the pharmaceutical company AstraZeneca. This candidate treatment, called Evusheld - or AZD7442 - is a combination of two monoclonal antibodies: tixagevimab and cilgavimab. The EMA is currently evaluating data from laboratory and animal studies. It says that it “will evaluate more data on the quality, safety and effectiveness of the medicine...

Contents

SOCIAL AFFAIRS - EMPLOYMENT
FUNDAMENTAL RIGHTS - SOCIETAL ISSUES
INSTITUTIONAL
EXTERNAL ACTION
SECTORAL POLICIES
EU RESPONSE TO COVID-19
NEWS BRIEFS